Key result
Cardiac surgery for congenital heart disease is associated with rare mortality in the current era, highlighting pitfalls in relying on mortality as a primary outcome measure.
Mortality following congenital heart surgery is rare in the current era, prompting a review of its utility and pitfalls as an outcome measure.
Mortality is insensitive for congenital heart surgery outcomes; leaves open validation of morbidity or functional endpoints for future trials.
Mortality following cardiac surgery for congenital heart disease is rare in the current times. In this review article, we explore current mortality rates, factors associated with mortality, and pitfalls in the use of mortality as a measure for assessing outcomes following congenital heart surgery.
No takes yet. Share an insight, caveat, or question.
Thiagarajan et al. (2011) studied this question. Cardiac surgery for congenital heart disease is associated with rare mortality in the current era, highlighting pitfalls in relying on mortality as a primary outcome measure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: